🇺🇸·19h agoResearch
NCT07684560: Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
Study type: INTERVENTIONAL. Phase: PHASE1.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 6, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE1.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
NIHR School for Public Health Research/7h ago
Inclusion of disadvantaged communities in public health research
CU Anschutz Medical/3h ago
CU Anschutz Marcus Institute for Brain Health Participates in National Traumatic Brain Injury Rehabilitation Trial
UNLP Health Sciences/3h ago
Llega Experiencia CIyTT 2026
UNLP Health Sciences/3h ago